Australia markets close in 1 hour 43 minutes
  • ALL ORDS

    7,549.50
    -153.40 (-1.99%)
     
  • ASX 200

    7,260.70
    -143.00 (-1.93%)
     
  • AUD/USD

    0.7237
    -0.0032 (-0.44%)
     
  • OIL

    71.40
    -0.57 (-0.79%)
     
  • GOLD

    1,746.70
    -4.70 (-0.27%)
     
  • BTC-AUD

    63,070.12
    -3,583.16 (-5.38%)
     
  • CMC Crypto 200

    1,140.28
    -85.25 (-6.96%)
     
  • AUD/EUR

    0.6176
    -0.0019 (-0.31%)
     
  • AUD/NZD

    1.0297
    -0.0021 (-0.20%)
     
  • NZX 50

    13,146.73
    -87.82 (-0.66%)
     
  • NASDAQ

    15,333.47
    -182.43 (-1.18%)
     
  • FTSE

    6,963.64
    -63.84 (-0.91%)
     
  • Dow Jones

    34,584.88
    -166.42 (-0.48%)
     
  • DAX

    15,490.17
    -161.63 (-1.03%)
     
  • Hang Seng

    23,955.18
    -965.58 (-3.87%)
     
  • NIKKEI 225

    30,500.05
    +176.75 (+0.58%)
     

Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2021 financial results will be released after market close on Thursday, August 5, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

After releasing second quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com.

Conference Call Information

When: Thursday, August 5, 2021 starting at 5:00 p.m. ET

Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)

Conference ID: 9146617

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com.

CONTACT: Contact Information: Investor Contact: McDavid Stilwell, CFO Coherus BioSciences, Inc. IR@coherus.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting